GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Outlook Therapeutics Inc (FRA:41O) » Definitions » Net Interest Income (for Banks)

Outlook Therapeutics (FRA:41O) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Outlook Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Outlook Therapeutics (FRA:41O) Business Description

Traded in Other Exchanges
Address
485 Route 1 South Building F, Suite 320, Iselin, NJ, USA, 08852
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.